Department of Physiology, Physiology Research Center, Research institute for infectious diseases of digestive system, School of Medicine, Ahvaz Jundi Shapur University of Medical Sciences, Ahvaz, Iran.
Dig Dis Sci. 2012 Jun;57(6):1496-503. doi: 10.1007/s10620-012-2051-5. Epub 2012 Jan 22.
Hydrogen sulfide (H(2)S) has been shown to display anti-inflammatory and antioxidant activities.
This study was designed to investigate the gastroprotective effect of sodium hydrosulfide (NaHS) on gastric mucosal lesions induced by ischemia-reperfusion (I/R) injury in rats and to determine the possible mechanism involved.
Fifty-sex male Wistar rats were randomly assigned into sham, control (I/R injury), propargylglycine (PAG)-, L-cysteine-, and NaHS-treated groups. To induce I/R lesions, the celiac artery was first clamped for 30 min (ischemia phase), followed by removal of the clamp artery to allow reperfusion for 3 h. Treated rats received PAG [50 mg/kg, intravenous (i.v.)] or NaHS (160, 320, or 640 ng/kg, i.v.) 5 min before reperfusion. The effect of L-cysteine pretreatment was also investigated. Plasma levels of cytokines and cortisol were measured by an enzyme-linked immunosorbent assay. The gastric tissue samples were collected to quantify the mRNA expression of interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and transforming growth factor (TGF-β) by quantitative real-time PCR.
The total area of gastric lesions significantly decreased following the administration of NaHS and L-cysteine. The highest area of mucosal lesions was observed in PAG-treated rats. The mRNA expression and plasma levels of IL-1β and TNF-α were significantly decreased in L-cysteine- and NaHS-treated rats in a dose-dependent manner. Slightly increased levels of TGF-β were observed in these test groups, but the difference was not statistically significant compared with the other groups. The plasma level of cortisol was also not affected by NaHS treatment.
Our findings indicate that a possible mechanism for the gastroprotective effect of H(2)S could be through the decreased mRNA expression and plasma release of proinflammatory cytokines.
硫化氢 (H(2)S) 已显示出抗炎和抗氧化作用。
本研究旨在探讨硫氢化钠 (NaHS) 对大鼠缺血再灌注 (I/R) 损伤诱导的胃黏膜损伤的胃保护作用,并确定涉及的可能机制。
将 58 只雄性 Wistar 大鼠随机分为假手术组、对照组 (I/R 损伤)、炔丙基甘氨酸 (PAG)、半胱氨酸和 NaHS 治疗组。为了诱导 I/R 损伤,首先夹闭腹腔动脉 30 分钟 (缺血期),然后去除夹闭的动脉以允许再灌注 3 小时。治疗大鼠在再灌注前 5 分钟接受 PAG [50 mg/kg,静脉 (i.v.)] 或 NaHS (160、320 或 640 ng/kg,i.v.)。还研究了 L-半胱氨酸预处理的效果。通过酶联免疫吸附试验测量细胞因子和皮质醇的血浆水平。收集胃组织样本,通过定量实时 PCR 定量白细胞介素-1β (IL-1β)、肿瘤坏死因子-α (TNF-α) 和转化生长因子 (TGF-β) 的 mRNA 表达。
NaHS 和 L-半胱氨酸给药后,胃损伤总面积明显减少。在 PAG 治疗的大鼠中观察到粘膜损伤的最大面积。L-半胱氨酸和 NaHS 治疗的大鼠中,IL-1β 和 TNF-α 的 mRNA 表达和血浆水平呈剂量依赖性降低。这些实验组中 TGF-β 的水平略有升高,但与其他组相比差异无统计学意义。皮质醇的血浆水平也不受 NaHS 治疗的影响。
我们的研究结果表明,H(2)S 的胃保护作用的可能机制可能是通过降低促炎细胞因子的 mRNA 表达和血浆释放。